Spiriva respimat and Neutrophil count increased - a phase IV clinical study of FDA data

Summary:

Neutrophil count increased is reported as a side effect among people who take Spiriva respimat (tiotropium bromide), especially for people who are female, 60+ old, also take Nucala,.

The phase IV clinical study analyzes which people have Neutrophil count increased when taking Spiriva respimat. It is created by eHealthMe based on reports of 9,653 people who have side effects when taking Spiriva respimat from the FDA, and is updated regularly.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

What is Neutrophil count increased?

Neutrophil count increased (excess than normal number of neutrophil a type of blood cell) is found to be associated with 942 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Neutrophil count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

9,653 people reported to have side effects when taking Spiriva respimat.
Among them, 14 people (0.15%) have Neutrophil count increased.

Could Spiriva respimat cause Neutrophil count increased?

Among these 14 people:

What is the gender of people who have Neutrophil count increased when taking Spiriva respimat? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Neutrophil count increased when taking Spiriva respimat? *

What are other drugs people take besides Spiriva respimat? *

What are other side effects people have besides Neutrophil count increased? *

White Blood Cell Count Increased: 14 people, 100.00%
Wheezing (a high-pitched whistling sound made while you breath): 14 people, 100.00%
Dyspnea (difficult or laboured breathing): 14 people, 100.00%
Sleep Disorder: 9 people, 64.29%
Eosinophil Count Increased: 9 people, 64.29%
Monocyte Count Increased: 8 people, 57.14%
Anti-Cyclic Citrullinated Peptide Antibody Positive: 6 people, 42.86%
Prostate Cancer: 6 people, 42.86%
Blood Immunoglobulin E Increased: 6 people, 42.86%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 6 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and have Neutrophil count increased?

- Check whether Neutrophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spiriva respimat:

Spiriva respimat (9,788 reports)

Browse all side effects of Spiriva respimat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil count increased:

Neutrophil count increased (942 drugs)

Browse all the conditions that are associated with Neutrophil count increased:

Neutrophil count increased (1,170 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide (the active ingredients of Spiriva respimat) and Spiriva respimat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.